aafq glp-1 Super Support + Akkermansia GLP-1 Consultation in Denver CO
Description
Purpose-built for physicians Q&A: Liraglutide outperforms colesevelam in reducing stool frequency in bile acid diarrhea Liraglutide reduced stool frequency in a small subset of patients with bile acid diarrhea and warrants consideration as a potential new treatment modality, according to research in The Lancet Gastroenterology and Hepatology
Semaglutide and Tirzepatide are FDA approved prescription medications used safely under medical supervision
The list continues to grow
, Burke, L
Bolder flavors: early research suggests GLP-1s can blunt taste perception
